Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Fehmi Tabak

Showing results (91-100 of 202) with videos related to

Pageof 21
Sort By:
Digestive Diseases and Sciences|May 15, 2010
Long-term effect of interferon therapy in patients with HBeAg positive chronic hepatitis B infectionHakan Senturk, Birol Baysal, Veysel Tahan, et al.
Journal of Gastroenterology and Hepatology|May 9, 2006
Efficacy of interferon alpha-2b and lamivudine combination treatment in comparison to interferon alpha-2b alone in chronic delta hepatitis: a randomized trialBillur Canbakan, Hakan Senturk, Fehmi Tabak, et al.
Wiener Klinische Wochenschrift|September 10, 2020
Risk factors for development of vancomycin-resistant enterococcal bacteremia among VRE colonizers : A retrospective case control studyAbdurrahman Kaya, Sibel Yıldız Kaya, Ilker Inanç Balkan, et al.
Nephron. Clinical Practice|September 18, 2010
Validation of biochemical markers for the prediction of liver fibrosis and necroinflammatory activity in hemodialysis patients with chronic hepatitis CMustafa Canbakan, Hakan Senturk, Billur Canbakan, et al.
The Turkish Journal of Gastroenterology : the Official Journal of Turkish Society of Gastroenterology|May 15, 2018
Immunosuppressive therapy and the risk of hepatitis B reactivation: Consensus reportBilgehan Aygen, Ahmet Muzaffer Demir, Mahmut Gümüş, et al.
Scientific Reports|December 1, 2025
Integrative bioinformatic and clinical validation reveals dynamic regulation of circulating microRNAs before and after antiretroviral therapy in HIV-positive patientsHaktan Sonmez, Zofia Wicik, Ceren Eyileten, et al.
Clinics and Research in Hepatology and Gastroenterology|August 1, 2017
A long-term multicenter study: Entecavir versus Tenofovir in treatment of nucleos(t)ide analogue-naive chronic hepatitis B patientsBircan Kayaaslan, Esragul Akinci, Alpay Ari, et al.
Frontiers in Immunology|May 21, 2025
Longitudinal analysis of hsa-miR-3163, hsa-miR-124-3p, hsa-miR-548c-3p, and hsa-miR-27a-3p as prognostic biomarkers in HIV-infected patientsIlker Inanç Balkan, Andleeb Shahzadi, Haktan Sönmez, et al.
Acta Microbiologica Et Immunologica Hungarica|March 21, 2022
A pan-resistant Myroides odoratimimus catheter-related bacteremia in a COVID-19 patient and review of the literatureAhmet Furkan Kurt, Bilgul Mete, Fatouma Moustapha Houssein, et al.
Diagnostic Microbiology and Infectious Disease|May 11, 2016
Diagnostic value of F-18 FDG PET/CT in patients with spondylodiscitis: Is dual time point imaging time worthy?Burcak Yilmaz Gunes, Cetin Onsel, Kerim Sonmezoglu, et al.
Pageof 21

Showing results (91-100 of 202) with videos related to

Sort By:
Pageof 21
Digestive Diseases and Sciences|May 15, 2010
Long-term effect of interferon therapy in patients with HBeAg positive chronic hepatitis B infectionHakan Senturk, Birol Baysal, Veysel Tahan, et al.
Journal of Gastroenterology and Hepatology|May 9, 2006
Efficacy of interferon alpha-2b and lamivudine combination treatment in comparison to interferon alpha-2b alone in chronic delta hepatitis: a randomized trialBillur Canbakan, Hakan Senturk, Fehmi Tabak, et al.
Wiener Klinische Wochenschrift|September 10, 2020
Risk factors for development of vancomycin-resistant enterococcal bacteremia among VRE colonizers : A retrospective case control studyAbdurrahman Kaya, Sibel Yıldız Kaya, Ilker Inanç Balkan, et al.
Nephron. Clinical Practice|September 18, 2010
Validation of biochemical markers for the prediction of liver fibrosis and necroinflammatory activity in hemodialysis patients with chronic hepatitis CMustafa Canbakan, Hakan Senturk, Billur Canbakan, et al.
The Turkish Journal of Gastroenterology : the Official Journal of Turkish Society of Gastroenterology|May 15, 2018
Immunosuppressive therapy and the risk of hepatitis B reactivation: Consensus reportBilgehan Aygen, Ahmet Muzaffer Demir, Mahmut Gümüş, et al.
Scientific Reports|December 1, 2025
Integrative bioinformatic and clinical validation reveals dynamic regulation of circulating microRNAs before and after antiretroviral therapy in HIV-positive patientsHaktan Sonmez, Zofia Wicik, Ceren Eyileten, et al.
Clinics and Research in Hepatology and Gastroenterology|August 1, 2017
A long-term multicenter study: Entecavir versus Tenofovir in treatment of nucleos(t)ide analogue-naive chronic hepatitis B patientsBircan Kayaaslan, Esragul Akinci, Alpay Ari, et al.
Frontiers in Immunology|May 21, 2025
Longitudinal analysis of hsa-miR-3163, hsa-miR-124-3p, hsa-miR-548c-3p, and hsa-miR-27a-3p as prognostic biomarkers in HIV-infected patientsIlker Inanç Balkan, Andleeb Shahzadi, Haktan Sönmez, et al.
Acta Microbiologica Et Immunologica Hungarica|March 21, 2022
A pan-resistant Myroides odoratimimus catheter-related bacteremia in a COVID-19 patient and review of the literatureAhmet Furkan Kurt, Bilgul Mete, Fatouma Moustapha Houssein, et al.
Diagnostic Microbiology and Infectious Disease|May 11, 2016
Diagnostic value of F-18 FDG PET/CT in patients with spondylodiscitis: Is dual time point imaging time worthy?Burcak Yilmaz Gunes, Cetin Onsel, Kerim Sonmezoglu, et al.
Pageof 21